The participants are patients with intractable cutaneous ulcers (e.g. rheumatic disease, peripheral arterial disease, chronic venous insufficiency, decubitus or burns).
Conditions
Interventions
Sponsors
Kumamoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria:
Exclusion criteria
Exclusion criteria: Patients who have ulcers with bone involvement. Patients who have ulcers with a history or suspected neoplasia. Patients who are in chemotherapy or radiation therapy on the skin ulcers. Patients with marked immunodeficiency (i.e., patients with severe liver failure, heart failure, hematologic failure or endocrine failure) Patients who have clinical signs of malnutrition or serum albumin <2 mg / dL. Patients who have severe infection. Patients who are pregnant or breastfeeding. Patients who are participating in another study. Patients who are judged inappropriate for this trial by their attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ulcer size (length, width, depth, mm) [Time Frame: 28 days] | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain of cutaneous wounds (Visual Analog Score for pain) [Time Frame: 28 days] | — |
Countries
Japan
Contacts
Public ContactMasatoshi Jinnin
Kumamoto University Department of Dermatology and Plastic Surgery, Faculty of Life Sciences
Outcome results
None listed